Application Of Aspirin In The Prevention Of Cardiovascular And Cerebrovascular Diseases In Hospitalized Type 2 Diabetes Patients

ObjectiveTo investigate the use of aspirin(ASA)in primary and secondary prevention of cardiovascular and cerebrovascular diseases in patients with type 2 diabetes in our hospital from January 2017 to June 2017 to promote rational use of drugs in the clinic and thereby reduce cardiovascular events in type 2 diabetes The occurrence of an incident and the reduction of the economic burden that patients may experience.MethodQuery medical records system and record the patient’s values of glycated hemoglobin/fasting blood glucose/ urea nitrogen/ uric acid/blood lipid /creatinine,and gender,age,height,weight,and whether or not smoking/ having urinary protein/ hypertension/ suffered from cardiovascular and cerebrovascular diseases in his or her lifetime,and whether there is a cardiovascular family history.According to the risk factors,the subjects were divided into secondary prevention group and primary prevention two groups according to the history of once suffered cardiovascular and cerebrovascular diseases.The primary prevention group is divided into 3 subgroups A1,A2,A3,based on risk factors to decide whether to recommend taking ASA.The usage rate of aspirin in each subgroup was counted.ResultA total of 432 patients with type 2 diabetes were included in this study.There were 279 patients in the primary prevention group,152,123,and 4 patients in the A1,A2,and A3 subgroups,respectively.The usage rate of ASA in the A1 subgroup was 32%,which is recommended taking aspirin.The A2 subgroup is 8.94%,which is determined by the clinicians according to the disease condition,The A3 subgroup is25%,and this group is not recommended to take ASA.The secondary prevention group’ usage rate is 54.25%.ConclusionAspirin usage rate is low in our hospital in the prevention of cardiovascular and cerebrovascular diseases in Type 2 diabetes...